Navigation Links
Mindray Medical International Announces Second Quarter 2008 Results
Date:9/3/2008

hareholders' equity:

Ordinary shares 13 14

Additional paid-in capital 260,107 268,333

Retained earnings 94,466 124,310

Accumulated other comprehensive loss 19,436 39,067

Total shareholders' equity 374,022 431,724

Total liabilities and shareholders' equity 446,714 700,212

MINDRAY MEDICAL INTERNATIONAL LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three months ended June 30, Six months ended June 30

2007 2008 2007 2008

US$ US$ US$ US$

(unaudited) (unaudited) (unaudited) (unaudited)

(In thousands, except (In thousands, except

share and per share data) share and per share data)

Net revenues

-PRC 36,280 57,846 63,159 100,637

- International 36,752 87,821 64,317 132,458

Net revenues 73,032 145,667 127,476 233,095

Cost of revenues (note

2) (32,104) (68,695) (55,985) (106,697)

Gross profit 40,928 76,972 71,491 126,398

Selling expenses (note

2) (10,529) (20,639) (16,722) (31,123)

General and

administrative

expenses (note 2) (2,714) (9,588) (5,700) (12,202)

Research and

development expenses

(note 2) (6,407) (12,322) (11,726) (20,744)

Expense of in-progress

research &

development
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 The ... online demonstration to support life extension technologies and awareness. ... UTC, Universal Coordinated Time, on March 21st 2015, in ... world. , Eric Schulke, Founder of MILE, says, ... act with urgency. The Movement for Indefinite Life Extension ...
(Date:2/26/2015)... , Feb. 26, 2015 BioEnterprise today ... companies have attracted more than $2 billion in growth ... local and national investors, strategic sources, state – including ... half of the $2 billion has been raised in ... comes on the heels of the BioEnterprise Midwest ...
(Date:2/26/2015)... MD (PRWEB) February 26, 2015 RURO, ... provider, released FreezerPro® version 6.2 – the latest update ... FreezerPro® reputation is that of a quick and easy ... work. With the latest version, RURO engineering has enhanced ... import to move large amounts of sample records. ...
(Date:2/26/2015)... Feb. 26, 2015 Ceres, Inc . ... in Oracle PartnerNetwork. In attaining Gold Level membership, Ceres ... establish Oracle-related knowledge in delivering Ceres, Persephone genome visualization ... customers. Originally developed for in-house use by ... in and out of massive amounts of genetic data, ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4RURO Releases FreezerPro® version 6.2 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4
... ... The use of codon optimization in gene synthesis has long been misunderstood. ... awarded two US patents covering the technology. DNA2.0,s approach goes beyond codon ... optimization. The algorithm associated with this patent has been proven to increase ...
... DENVER, June 10 Building on the momentum of ... http://www.stemcellaware.com ) will hold the sixth Stem Cell Awareness ... group,s last event, in Punta Gorda, Florida, drew past ... as well as members of the public interested in ...
... 10 Strativa Pharmaceuticals, the proprietary products division of ... (NYSE: PRX ), today announced that the ... New Drug Application (NDA) for ondansetron orally dissolving film ... for the prevention of nausea and vomiting associated with ...
Cached Biology Technology:DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 3Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 2Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 3Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA 2Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA 3
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/12/2015)... Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62/113114 for DISTRIBUTED METHOD AND SYSTEM ... The patent further establishes NXT-ID,s position in the emerging ... portfolio the ability for multiple devices to collaborate with ...
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... (April 27, 2009) In an in vitro study, led ... researchers discovered how a protein called SUMO (Small Ubiquitin-related ... of chromatin to regulate expression of genes. Chromatin is ... up chromosomes. The interaction between SUMO and the enzyme ...
... macrophages, immune cells that can engulf and poison bacteria ... A new study from the University of Illinois disproves ... PLoS ONE , shows that macrophages focus their most ... targets outside the cytoplasm. Macrophages are voracious eaters ...
... 27, 2009 Landfilled waste decomposes in the ... of methane. Landfills are classified as the second-largest ... landfill gas contains numerous non-methane hydrocarbons that are ... through biochemical reactions during waste degradation. Microbial ...
Cached Biology News:SUMO protein guides chromatin remodeler to suppress genes 2New study overturns orthodoxy on how macrophages kill bacteria 2New study overturns orthodoxy on how macrophages kill bacteria 3Landfill cover soil methane oxidation underestimated 2
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Request Info...
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... The Neural Stem Cell Expansion Kit - ... in vitro NSC expansion as a monolayer ... specially formulated N-2 Plus Media Supplement, which has ... K.K. et al . (1996) Genes & ...
Biology Products: